Amgen Inc
General Information
Identification Code: 42243575237-50
Website: http://www.amgen.com
Entity Form: Corporation
Registration Category: Companies & groups
Registration Date: 2/7/2011
Last Update: 3/18/2024
EP Accredited Number: 3
Mission & Interests
Goals: Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. Amgen was incorporated in California in 1980 and became a Delaware corporation in 1987. Amgen has a presence in approximately 100 countries worldwide. It operates in one business segment : human therapeutics.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Budget
- Business and industry
- Competition
- Consumers
- Customs
- Digital economy and society
- Economy, finance and the euro
- Education and training
- Employment and social affairs
- Enlargement
- Environment
- External relations
- Institutional affairs
- Justice and fundamental rights
- Public health
- Research and innovation
- Single market
- Taxation
- Trade
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: Engage governments and policy makers worldwide on issues important to Amgen to: Ensure patients have access to medicines they need. Provide coverage and reimbursement that reward innovation
Introduce sound, science-based regulation. Enable biotechnology research and development (R&D)
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: One Amgen Center Drive
Post Code: 91320-1799
City: Thousand Oaks, California
Country: UNITED STATES
Phone:
Indic Phone: 1
Phone Number: 8054471000
EU Office
Address: 5-7 Telecomlaan
City: Diegem
Country: BELGIUM
Phone:
Indic Phone: 32
Phone Number: 27752813
Financial Data
Closed Year:
Start Date:
End Date:
Funding Sources:
Contributions:
Total Budget: 0
Grants:
Current Year:
Grants:
Complementary Information: Increase in annual amount declared due to acquisition of Horizon Therapeutics, which already had activities covered by the scope of the Register.
Membership Information
Members10 Percent: 5
Members25 Percent: 4
Members50 Percent: 2
Members75 Percent: 1
Members: 12
Members F T E: 3.25
Structure
Structure Type: Structure
Is Member Of: N.A.
Organisation Members: Amgen is a member of the following organizations in Brussels:
AmCham EU - American Chamber of Commerce to the EU
EFPIA – European Federation of Pharmaceutical Industries and Associations
Eucope - European Confederation of Pharmaceutical Entrepreneurs
EPC - European Policy Centre
Friends of Europe
European Business Summit
Current Job Opportunities
mid-levelBrussels, Francefull-time
Posted: 8/21/2025